For acute contact: In a ---- hr-acute contact toxicity study, honey bees {species} were exposed to {test material} administered {topically to region} at an application rate of {0 (negative control, solvent control), x1, x2, --- xn g a.i./bee} in accordance with the { specifiy the guideline followed}. The NOEL and LD50 values were X and X g a.i./bee, respectively. The test material is classified as [indicate the relative toxicity] to honey bees in accordance with the classification of Atkins (1981).

 

[Briefly describe mortality and sublethal effects. If there is no toxicity, state that there were no compound related effects. Compare with reference chemical toxicity, if used.]

 

This study is classified as [enter acceptability classification e.g. acceptable/unacceptable/ supplementary) and {satisfies/does not satisfy} the guideline requirement for acute contact toxicity study for honey bees.

 

For acute oral: In a --- hr-acute oral toxicity study, honey bees {species} were exposed to {test material} administered in the feed solution at an application rate of {0 (negative control, solvent control), x1, x2, --- xn g a.i./bee) in accordance with the --- {specify the guideline followed}. The NOEC and LC50 values were X and X g a.i./bee, respectively. The test material is classified as [indicate the relative toxicity] to honey bees in accordance with the classification of Atkins (1981).

 

[Briefly describe mortality and sublethal effects. If there is no toxicity, state that there were no compound related effects. Compare with reference chemical toxicity.]

 

This study is classified as [enter acceptability classification e.g. acceptable/unacceptable/ supplementary) and {satisfies/does not satisfy} the guideline requirement for {acute oral toxicity} study for honey bees.

 

Results Synopsis:

 

Test organisms and test organism age:

Test type:

 

For acute contact:

 

hr LD50: { g a.i./bee} 95% C.I.: { to g a.i./bee}

hr NOEL: { g a.i./bee}

Probit Slope: {) 95% C.I.: { to }

Endpoint(s) Effected: {}

 

For acute oral:

 

---- hr LC50: { g a.i./bee} 95% C.I.: { to g a.i./bee}

---- hr NOEL: { g a.i./bee}

Probit Slope: {} 95% C.I.: { to }

Endpoint(s) Effected: {}